Atara Biotherapeutics (ATRA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

ATRA Atara Biotherapeutics

Watchlist

13.510
-0.750-5.26%

Trading Nov 14 11:13 ET

77.81MMarket Cap-533P/E (TTM)

Intraday

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Atara Biotherapeutics to Participate at the Stifel 2024 Healthcare Conference
BusinesswireNov 13 16:01 ET
CCORF Maintains Atara Biotherapeutics(ATRA.US) With Buy Rating, Raises Target Price to $21
Moomoo NewsNov 13 08:31 ET · Ratings
Atara Biotherapeutics Price Target Raised to $21 From $13 at Canaccord
TipRanksNov 13 07:51 ET
Atara Biotherapeutics Advances With Strategic Partnerships
TipRanksNov 12 16:45 ET
Atara Biotherapeutics: Cash Runway Into 2027 Enables Key Pipeline Readouts >ATRA
Dow JonesNov 12 16:19 ET
Atara Biotherapeutics: First Patient Dosed for ATA3219 Non-Hodgkin's Lymphoma Study; Initial Clinical Data Expected 1Q of 2025 >ATRA
Dow JonesNov 12 16:18 ET

Comments

joeyboulevard

Nov 5 07:16

$Atara Biotherapeutics (ATRA.US)$ Looks good!

Jaguar8

Sep 5 15:19

Atara Biotherapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Adiumentum Capital Fund I LP(19.99%),Adiumentum Capital Fund I GP LLC(19.99%), etc.

$Atara Biotherapeutics (ATRA.US)$

FattyChick

Sep 5 08:15

$Atara Biotherapeutics (ATRA.US)$ Should have a re-entry at 7.70

rmgm

Sep 4 08:19

$Atara Biotherapeutics (ATRA.US)$ over 30 million cash in the books acccording to there 30th of June Financial report , will have additional extra cash of 36 million on 5 September from institutional investors and big pharma company by issuing them around 4 million shares at 8.25 $ , will further receive 20 million + 60 Million by Pierre Fabre Pharmaceuticals once FDA approves there EBV drug in Jan 2025 .
Should see increased acitivity soon as all these large investors have interest in this comp...